Compare Manhattan Associates Inc (MANH) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manhattan Associates Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Manhattan Associates Inc trades at $159.61 (market cap $9.79B), while Regeneron Pharmaceuticals Inc trades at $673.67 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 7.2× Manhattan Associates Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Manhattan Associates Inc pays none. Which is the better fit depends on your goals.
| MANH | REGN | |
|---|---|---|
Market Cap | $9.79B | $70.47B |
Sector | Technology | Health |
52-Week High | $227.94 | $812.27 |
52-Week Low | $120.88 | $545.46 |
Enterprise Value | $9.62B | $64.42B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
